lorazepam has been researched along with Delusional Disorder in 15 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A young male with schizophrenia, dependence syndrome (multiple drug use) and a severe depressive episode develops a serotonin syndrome with Sertraline and Ziprasidone." | 7.85 | [Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline]. ( Grabe, HJ; Janowitz, D; Schomerus, G; Speerforck, S, 2017) |
| "A case of a male patient with schizophrenic illness who developed neuroleptic malignant syndrome (NMS) following treatment with olanzapine is reported." | 7.75 | Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia. ( Borkar, HA; Chandak, S; Srivastava, A, 2009) |
| "A young male with schizophrenia, dependence syndrome (multiple drug use) and a severe depressive episode develops a serotonin syndrome with Sertraline and Ziprasidone." | 3.85 | [Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline]. ( Grabe, HJ; Janowitz, D; Schomerus, G; Speerforck, S, 2017) |
| "A case of a male patient with schizophrenic illness who developed neuroleptic malignant syndrome (NMS) following treatment with olanzapine is reported." | 3.75 | Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia. ( Borkar, HA; Chandak, S; Srivastava, A, 2009) |
| "However in those cases withdrawal symptoms were distinct and the medical intervention was needed." | 1.38 | [Description of a patient with schizophrenia and coexisting megadose lorazepam dependence with slightly expressed withdrawl symptoms during drug reduction. A case report]. ( Badura-Brzoza, K; Pasierb, N; Schylla, A; Scisło, P, 2012) |
| "The patient diagnosed with paranoid schizophrenia had been treated with a combination of conventional antipsychotics for many years." | 1.35 | Olanzapine monotherapy in a long-term treatment for schizophrenia: case study. ( Dadić-Hero, E; Medved, P; Petranović, D; Ruzić, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Speerforck, S | 1 |
| Janowitz, D | 1 |
| Schomerus, G | 1 |
| Grabe, HJ | 1 |
| Schylla, A | 1 |
| Scisło, P | 1 |
| Badura-Brzoza, K | 1 |
| Pasierb, N | 1 |
| Srivastava, A | 1 |
| Borkar, HA | 1 |
| Chandak, S | 1 |
| Ruzić, K | 1 |
| Dadić-Hero, E | 1 |
| Petranović, D | 1 |
| Medved, P | 1 |
| Hewer, W | 1 |
| Kauder, E | 1 |
| Vierling, P | 1 |
| Enterman, JH | 1 |
| van Dijk, D | 1 |
| Zacher, JL | 1 |
| Roche-Desilets, J | 1 |
| Emes, CE | 1 |
| Millson, RC | 1 |
| Kingsbury, SJ | 1 |
| Puckett, KM | 1 |
| Jaspert, A | 1 |
| Ebert, D | 1 |
| Klimke, A | 1 |
| Klieser, E | 1 |
| Kanofsky, JF | 1 |
| Lindenmayer, JP | 1 |
| Konafsky, D | 1 |
| Little, JD | 1 |
| Taghavi, EH | 1 |
| Greenberg, WM | 1 |
| Triana, JP | 1 |
| Karajgi, B | 1 |
| Ward, ME | 1 |
| Saklad, SR | 1 |
| Ereshefsky, L | 1 |
15 other studies available for lorazepam and Delusional Disorder
| Article | Year |
|---|---|
[Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline].
Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lor | 2017 |
[Description of a patient with schizophrenia and coexisting megadose lorazepam dependence with slightly expressed withdrawl symptoms during drug reduction. A case report].
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Humans; Lorazepam; Male; Schizophrenia, Paranoid; Sub | 2012 |
Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Consciousness; Humans; Hypnotics and Sedatives; Lorazepam; Ma | 2009 |
Olanzapine monotherapy in a long-term treatment for schizophrenia: case study.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response | 2009 |
Fatal pulmonary embolism following antipsychotic treatment and physical restraint.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Fatal Outcome; Female; Haloperidol; Heart Arrest; Heart | 2009 |
The curious case of a catatonic patient.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Delayed-Acti | 2011 |
Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Approval; Drug Interactions; Drug Therapy, Combination; | 2005 |
Risperidone-induced priapism.
Topics: Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Humans; Isoxazoles; Lithium Carbon | 1994 |
Effects of fluoxetine on serum clozapine levels.
Topics: Adult; Clonazepam; Clozapine; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; F | 1995 |
[Benzodiazepine monotherapy in acute schizophrenia].
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Diazepam; Humans; Lorazepam; Male; Schizophrenia; Schizop | 1994 |
Sudden death after intravenous application of lorazepam in a patient treated with clozapine.
Topics: Adult; Clozapine; Death, Sudden; Drug Interactions; Drug Therapy, Combination; Humans; Injections, I | 1994 |
Relapse in a clozapine responder following lorazepam withdrawal.
Topics: Adult; Clozapine; Drug Therapy, Combination; Humans; Lorazepam; Male; Recurrence; Schizophrenia, Par | 1993 |
Disinhibition after lorazepam augmentation of antipsychotic medication.
Topics: Adult; Aggression; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination | 1991 |
Lorazepam in the treatment of psychotic symptoms.
Topics: Adult; Hallucinations; Humans; Lorazepam; Male; Schizophrenia, Paranoid | 1986 |
Lorazepam for the treatment of psychotic agitation.
Topics: Adult; Aggression; Humans; Injections, Intramuscular; Lorazepam; Male; Psychomotor Agitation; Schizo | 1986 |